Skip to main content

and
  1. No Access

    Article

    Technical feasibility of robotic vs. laparoscopic surgery for locally advanced colorectal cancer invading the urinary bladder

    The aim of this study was to determine if robotic surgery can reproduce the technical advantages and oncologic outcomes of laparoscopic surgery for the treatment of locally advanced colorectal cancer invading ...

    Yu-Tso Liao, John Huang, Tzu-Chun Chen, Ji-Shiang Hung in Techniques in Coloproctology (2022)

  2. No Access

    Article

    Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study

    Current guidelines suggest that adjuvant chemotherapy (AC) be administered to all locally advanced (clinically T3–4 or N-positivity) rectal cancer patients undergoing neoadjuvant chemoradiotherapy (nCRT) and r...

    Yu-Tso Liao, Yu-Lin Lin, John Huang in International Journal of Colorectal Disease (2021)

  3. Article

    Open Access

    C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer

    C1GALT1 controls the crucial step of GalNAc-type O-glycosylation and is associated with both physiologic and pathologic conditions, including cancers. EPH receptors comprise the largest family of receptor tyro...

    Po-Chu Lee, Syue-Ting Chen, Ting-Chun Kuo, Tzu-Chi Lin, Mei-Chun Lin in Oncogene (2020)

  4. No Access

    Article

    BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer

    The prognostic implication of BRAF mutant colorectal cancer remains paradoxical. Records of BRAF mutant and wild-type colorectal cancer patients at all stages were reviewed. Clinicopathologic features, including...

    Kuo-Hsing Chen, Yu-Lin Lin, Jau-Yu Liau, Jia-Huei Tsai, Li-Hui Tseng in Medical Oncology (2016)

  5. No Access

    Article

    Is Surgery Indicated for Patients with Symptomatic Nonfunctioning Pancreatic Neuroendocrine Tumor and Unresectable Hepatic Metastases?

    Patients with advanced pancreatic neuroendocrine tumor, even in the presence of unresectable hepatic metastases, have survival usually measured in years than in months. Theoretically, we would have reason to r...

    Ji-Shiang Hung, Ming-Chu Chang, Po-Huang Lee, Yu-Wen Tien in World Journal of Surgery (2007)